LONGEVITY with Nathalie Niddam
Episode #241: Dr. Elizabeth Yurth & The Quest for Lifelong Vitality: Exploring Myths and Medicine
Jun 11, 2024
Dr. Elizabeth Yurth discusses anti-aging medicine, research bias, and gender differences in longevity studies. They explore adapting treatments for individuals, the importance of social connections for longevity, and the impact of stress on health. The episode also touches on the benefits of rapamycin, acarbose, and NDGA, and the versatility of LDN in treating various conditions.
01:26:13
Episode guests
AI Summary
AI Chapters
Episode notes
Podcast summary created with Snipd AI
Quick takeaways
- Dr. Yurth emphasizes validating scientific claims for anti-aging medicine.
- LDN offers relief from pain and gut issues at lower doses.
Deep dives
Repurposed Drug: Low Dose Naltrexone (LDN)
Low Dose Naltrexone (LDN) is a repurposed drug originally approved in 1984 for drug and alcohol addiction treatment at doses of 50 to 100 milligrams. At lower doses, LDN has shown significant benefits, including reduced pain, improved mood, less depression, and alleviation of other complications like gut issues. LDN works by blocking opioid receptors and toll-like receptors, leading to a marked reduction in pro-inflammatory cytokines, making it beneficial for various conditions, including inflammatory bowel diseases, autoimmune diseases, arthritis, cancer, and gut issues.
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
